Despite dramatic advances in medicine, health care still causes harm too often, costs too much, and improves too slowly. This has led many payers and policy makers to focus on improving value, which includes quality, patient experience, and cost of care. Despite national attention on providing value in medicine, measures of value have been slow to emerge. We believe that professional societies have an opportunity to collaborate and develop standards that include not only outcomes but also patient experience and cost.
Dietz JR, Pronovost P. Time to Focus on Value-Based Metrics for Cancer Care? JAMA Oncol. 2020;6(9):1325–1326. doi:10.1001/jamaoncol.2020.0792
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.